# EDGAR Filing Document

**Accession Number:** 0001618205
**File Stem:** 0001104659-25-086145
**Filing Date:** 2025-9
**Character Count:** 74662
**Document Hash:** e2316b08bec27b02c5eb2c4e431b35b9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001104659-25-086145.hdr.sgml**: 20250902

**ACCESSION NUMBER**: 0001104659-25-086145

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250902

**EFFECTIVENESS DATE**: 20250902

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Birchview Capital, LP
- **CENTRAL INDEX KEY:** 0001618205

**ORGANIZATION NAME:**
- **EIN:** 383924650
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-16416
- **FILM NUMBER:** 251283602

**BUSINESS ADDRESS:**
- **STREET 1:** 688 PINE STREET, SUITE D
- **STREET 2:** C/O BIRCHVIEW CAPITAL
- **CITY:** BURLINGTON
- **STATE:** VT
- **ZIP:** 05401
- **BUSINESS PHONE:** 802-923-3826

**MAIL ADDRESS:**
- **STREET 1:** 688 PINE STREET, SUITE D
- **STREET 2:** C/O BIRCHVIEW CAPITAL
- **CITY:** BURLINGTON
- **STATE:** VT
- **ZIP:** 05401

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001618205

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Birchview Capital, LP

**Address:** 688 Pine Street, Burlington, VT 05401

**Telephone number:** 802-923-3826

**Name of agent for service:** YCS SERVICES LLC

**Agent Address:** 1000 N King Street, Wilmington, DE 19801

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-16416

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                      | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                             | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Masimo Corporation                  | 574795100 | 04/29/2025     | An advisory vote to approve the compensation of our names executive officers.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          10200 |                0 | FOR         |                                    10200 | FOR                         |  |
| Masimo Corporation                  | 574795100 | 04/29/2025     | An advisory vote to approve the compensation of our names executive officers.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |           1080 |                0 | FOR         |                                     1080 | FOR                         |  |
| Boston Scientific Corporation       | 101137107 | 05/01/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              9 |                0 | FOR         |                                        9 | FOR                         |  |
| Halozyme Therapeutics, Inc.         | 40637H109 | 05/01/2025     | To approve, by a non-binding advisory vote, the compensation of the Company's named executive officers.                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          10000 |                0 | FOR         |                                    10000 | FOR                         |  |
| Biohaven LTD                        | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |           7000 |                0 | FOR         |                                     7000 | FOR                         |  |
| Biohaven LTD                        | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |            365 |                0 | FOR         |                                      365 | FOR                         |  |
| Bristol-Myers Squibb Company        | 110122108 | 05/06/2025     | Advisory vote to approve the compensation of our names executive officers.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          26000 |                0 | FOR         |                                    26000 | FOR                         |  |
| Eli Lilly and Company               | 532457108 | 05/05/2025     | Approval, on an advisory basis, of the compensation paid to the company's named executive officers.                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         |                                        1 | FOR                         |  |
| Dexcom, Inc.                        | 252131107 | 05/08/2025     | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.                                                                                      | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | FOR         |                                        3 | FOR                         |  |
| Abbvie Inc.                         | 00287Y109 | 05/09/2025     | Say on Pay - An advisory vote on the approval of executive compensation.                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              4 |                0 | FOR         |                                        4 | FOR                         |  |
| Royalty Pharma PLC                  | G7709Q104 | 05/12/2025     | A non-binding advisory vote to approve executive compensation that may become payable in connection with the transaction contemplated by the Membership Interest Purchase Agreement.                                         | SECTION 14A SAY-ON-PAY VOTES |             21 |                0 | FOR         |                                       21 | FOR                         |  |
| Prothena Corp                       | G72800108 | 05/13/2025     | To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.                                                                | SECTION 14A SAY-ON-PAY VOTES |          18000 |                0 | FOR         |                                    18000 | FOR                         |  |
| Prothena Corp                       | G72800108 | 05/13/2025     | To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.                                                                | SECTION 14A SAY-ON-PAY VOTES |         180000 |                0 | FOR         |                                   180000 | FOR                         |  |
| Cytokinetics, Incorporated          | 23282W605 | 05/13/2025     | To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.                                                                            | SECTION 14A SAY-ON-PAY VOTES |          10000 |                0 | FOR         |                                    10000 | FOR                         |  |
| Mannkind Corporation                | 56400P706 | 05/14/2025     | To approve, on an advisory basis, the compensation of the named executive officers of Mannkind, as disclosed in Mankind's proxy statement for the Annual Meeting.                                                            | SECTION 14A SAY-ON-PAY VOTES |             11 |                0 | FOR         |                                       11 | FOR                         |  |
| Springworks Therapeutics Inc        | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation.                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |            600 |                0 | FOR         |                                      600 | FOR                         |  |
| Springworks Therapeutics Inc        | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation.                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |           7400 |                0 | FOR         |                                     7400 | FOR                         |  |
| Travere Therapeutics, Inc.          | 89422G107 | 05/15/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         128000 |                0 | FOR         |                                   128000 | FOR                         |  |
| Aurinia Pharmaceuticals Inc.        | 05156V102 | 05/15/2025     | To approve, on a non-binding advisory basis, a "say on pay" resolution regarding the Company's executive compensation set forth in the Company's Proxy Statement/Circular.                                                   | SECTION 14A SAY-ON-PAY VOTES |             19 |                0 | FOR         |                                       19 | FOR                         |  |
| Collegium Pharmaceutical, Inc.      | 19459J104 | 05/15/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |              6 |                0 | FOR         |                                        6 | FOR                         |  |
| Lyell Immunopharma, Inc.            | 55083R104 | 05/15/2025     | Approval, on a non-binding advisory basis, of the company's named executive officers.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |             14 |                0 | FOR         |                                       14 | FOR                         |  |
| Travere Therapeutics, Inc.          | 89422G107 | 05/15/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          10000 |                0 | FOR         |                                    10000 | FOR                         |  |
| Ultragenyx Pharmaceutical Inc.      | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |           1600 |                0 | FOR         |                                     1600 | FOR                         |  |
| Ultragenyx Pharmaceutical Inc.      | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          14400 |                0 | FOR         |                                    14400 | FOR                         |  |
| Innoviva Inc                        | 45781M101 | 05/19/2025     | Approval of a non-binding advisory resolution regarding executive compensation.                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | FOR         |                                        3 | FOR                         |  |
| Biomarin Pharmaceutical Inc.        | 09061G101 | 05/20/2025     | To approve, on an advisory basis, the compensation of the Company's Named executive officers as disclosed in the Proxy Statement.                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              8 |                0 | FOR         |                                        8 | FOR                         |  |
| Catalyst Pharmaceuticals, Inc.      | 14888U101 | 05/20/2025     | To approve, on an advisory basis, the 2024 compensation of our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |             13 |                0 | FOR         |                                       13 | FOR                         |  |
| QuidelOrtho Corporation             | 219798105 | 05/20/2025     | Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          30620 |                0 | FOR         |                                    30620 | FOR                         |  |
| QuidelOrtho Corporation             | 219798105 | 05/20/2025     | Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |           3675 |                0 | FOR         |                                     3675 | FOR                         |  |
| QuidelOrtho Corporation             | 219798105 | 05/20/2025     | Approval of, on an advisory basis, the compensation of QuidelOrtho's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |           3500 |                0 | FOR         |                                     3500 | FOR                         |  |
| Treace Medical Concepts, Inc.       | 89455T109 | 05/20/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          16835 |                0 | FOR         |                                    16835 | FOR                         |  |
| Treace Medical Concepts, Inc.       | 89455T109 | 05/20/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         147515 |                0 | FOR         |                                   147515 | FOR                         |  |
| Alkermes PLC                        | G01767105 | 05/21/2025     | To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          50000 |                0 | FOR         |                                    50000 | FOR                         |  |
| Arbutus Biopharma Corporation       | 03879J100 | 05/21/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the Proxy Statement/Circular.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | FOR         |                                        3 | FOR                         |  |
| Dentsply Sirona Inc.                | 24906P109 | 05/21/2025     | Approval, by a non-binding vote, of the Company's executive compensation for 2024.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |             43 |                0 | FOR         |                                       43 | FOR                         |  |
| Geron Corporation                   | 374163103 | 05/21/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in our Proxy Statement.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |            106 |                0 | FOR         |                                      106 | FOR                         |  |
| Merus N.V.                          | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive offivers.                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         |                                        1 | FOR                         |  |
| Neurocrine Biosciences, Inc.        | 64125C109 | 05/21/2025     | Advisory vote on the compensation paid to the Company's named executive officers.                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          26000 |                0 | FOR         |                                    26000 | FOR                         |  |
| Neurocrine Biosciences, Inc.        | 64125C109 | 05/21/2025     | Advisory vote on the compensation paid to the Company's named executive officers.                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |           4000 |                0 | FOR         |                                     4000 | FOR                         |  |
| Capricor Therapeutics, Inc.         | 14070B309 | 05/22/2025     | Approval of named executive officer compensation, on a non-binding advisory basis.                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              2 |                0 | FOR         |                                        2 | FOR                         |  |
| Castle Biosciences Inc.             | 01484C105 | 05/21/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          78000 |                0 | FOR         |                                    78000 | FOR                         |  |
| Castle Biosciences Inc.             | 01484C105 | 05/21/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          10000 |                0 | FOR         |                                    10000 | FOR                         |  |
| Maravai Lifesciences Holdings, Inc. | 56600D107 | 05/22/2025     | To approve, on a non-binding advisory basis, the compensation of Maravai's named executive officers.                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |             20 |                0 | FOR         |                                       20 | FOR                         |  |
| Pulmonx Corporation                 | 745848101 | 05/21/2025     | To conduct a non-binding advisory vote to approve our executive compensation.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          46000 |                0 | FOR         |                                    46000 | FOR                         |  |
| Pulmonx Corporation                 | 745848101 | 05/21/2025     | To conduct a non-binding advisory vote to approve our executive compensation.                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |           5000 |                0 | FOR         |                                     5000 | FOR                         |  |
| Scholar Rock Holding Corporation    | 80706P103 | 05/21/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          14221 |                0 | FOR         |                                    14221 | FOR                         |  |
| Scholar Rock Holding Corporation    | 80706P103 | 05/21/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |            800 |                0 | FOR         |                                      800 | FOR                         |  |
| Cassava Sciences, Inc.              | 14817C107 | 05/22/2025     | To approve, by a non-binding advisory vote, 2024 executive compensation for the Company's named executive officers.                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |             10 |                0 | FOR         |                                       10 | FOR                         |  |
| Orthopediatrics Corp.               | 68752L100 | 05/23/2025     | To approve, on an advisory basis, the resolution approving the compensation of our named executive officers.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          18000 |                0 | FOR         |                                    18000 | FOR                         |  |
| Orthopediatrics Corp.               | 68752L100 | 05/23/2025     | To approve, on an advisory basis, the resolution approving the compensation of our named executive officers.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |           2000 |                0 | FOR         |                                     2000 | FOR                         |  |
| Karyopharm Therapeutics Inc.        | 48576U205 | 05/28/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as described in the proxy statement.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          19033 |                0 | FOR         |                                    19033 | FOR                         |  |
| Karyopharm Therapeutics Inc.        | 48576U205 | 05/28/2025     | To recommend, on an advisory basis, the frequency of future non-binding advisory votes on the compensation of our named executive officers.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          19033 |                0 | 1 YEAR      |                                    19033 | FOR                         |  |
| Karyopharm Therapeutics Inc.        | 48576U205 | 05/28/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as described in the proxy statement.                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |           7000 |                0 | FOR         |                                     7000 | FOR                         |  |
| Karyopharm Therapeutics Inc.        | 48576U205 | 05/28/2025     | To recommend, on an advisory basis, the frequency of future non-binding advisory votes on the compensation of our named executive officers.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           7000 |                0 | 1 YEAR      |                                     7000 | FOR                         |  |
| Tela Bio, Inc.                      | 087238108 | 05/28/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |         139500 |                0 | FOR         |                                   139500 | FOR                         |  |
| Tela Bio, Inc.                      | 087238108 | 05/28/2025     | To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on the compensation of the Company's named executive officers.                                                                | SECTION 14A SAY-ON-PAY VOTES |         139500 |                0 | 1 YEAR      |                                   139500 | FOR                         |  |
| Tela Bio, Inc.                      | 087238108 | 05/28/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          15500 |                0 | FOR         |                                    15500 | FOR                         |  |
| Tela Bio, Inc.                      | 087238108 | 05/28/2025     | To approve, on a non-binding, advisory basis, the preferred frequency of future advisory votes on the compensation of the Company's named executive officers.                                                                | SECTION 14A SAY-ON-PAY VOTES |          15500 |                0 | 1 YEAR      |                                    15500 | FOR                         |  |
| Acadia Pharmaceuticals Inc.         | 004225108 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          21000 |                0 | FOR         |                                    21000 | FOR                         |  |
| Acadia Pharmaceuticals Inc.         | 004225108 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         202000 |                0 | FOR         |                                   202000 | FOR                         |  |
| Mirum Pharmaceuticals, Inc.         | 604749101 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              3 |                0 | FOR         |                                        3 | FOR                         |  |
| Amphastar Pharmaceuticals Inc.      | 03209R103 | 06/02/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              6 |                0 | FOR         |                                        6 | FOR                         |  |
| Outset Medical, Inc.                | 690145206 | 06/02/2025     | To approve, on a non-binding basis, the 2024 compensation of our named executive officers.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |           2384 |                0 | FOR         |                                     2384 | FOR                         |  |
| Outset Medical, Inc.                | 690145206 | 06/02/2025     | To approve, on a non-binding basis, the 2024 compensation of our named executive officers.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          22200 |                0 | FOR         |                                    22200 | FOR                         |  |
| 10X Genomics, Inc.                  | 88025U109 | 06/03/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |           4000 |                0 | FOR         |                                     4000 | FOR                         |  |
| 10X Genomics, Inc.                  | 88025U109 | 06/03/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          56000 |                0 | FOR         |                                    56000 | FOR                         |  |
| Apellis Pharmaceuticals Inc.        | 03753U106 | 06/03/2025     | To hold an advisory vote to approve the compensation paid to our named executive officers.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |          14000 |                0 | FOR         |                                    14000 | FOR                         |  |
| Apellis Pharmaceuticals Inc.        | 03753U106 | 06/03/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers.                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          14000 |                0 | 1 YEAR      |                                    14000 | FOR                         |  |
| Kiniska Pharmaceuticals             | G52694109 | 06/02/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              6 |                0 | FOR         |                                        6 | FOR                         |  |
| Kiniska Pharmaceuticals             | G52694109 | 06/02/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          30000 |                0 | FOR         |                                    30000 | FOR                         |  |
| Stoke Therapeutics, Inc.            | 86150R107 | 06/03/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |              4 |                0 | FOR         |                                        4 | FOR                         |  |
| Stoke Therapeutics, Inc.            | 86150R107 | 06/03/2025     | To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                       | SECTION 14A SAY-ON-PAY VOTES |              4 |                0 | 1 YEAR      |                                        4 | FOR                         |  |
| Stoke Therapeutics, Inc.            | 86150R107 | 06/03/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |          24641 |                0 | FOR         |                                    24641 | FOR                         |  |
| Stoke Therapeutics, Inc.            | 86150R107 | 06/03/2025     | To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                       | SECTION 14A SAY-ON-PAY VOTES |          24641 |                0 | 1 YEAR      |                                    24641 | FOR                         |  |
| Stoke Therapeutics, Inc.            | 86150R107 | 06/03/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         185359 |                0 | FOR         |                                   185359 | FOR                         |  |
| Stoke Therapeutics, Inc.            | 86150R107 | 06/03/2025     | To indicate, on an advisory basis, the preferred frequency of future stockholder advisory votes to approve the compensation of the Company's named executive officers.                                                       | SECTION 14A SAY-ON-PAY VOTES |         185359 |                0 | 1 YEAR      |                                   185359 | FOR                         |  |
| Cue Biopharma, Inc.                 | 22978P106 | 06/04/2025     | The approval, on a non-binding advisory basis, of the compensation of our named executive officers.                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |              9 |                0 | FOR         |                                        9 | FOR                         |  |
| Keros Therapeutics, Inc.            | 492327101 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.                                                                               | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | FOR         |                                     1000 | FOR                         |  |
| Keros Therapeutics, Inc.            | 492327101 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.                                                                               | SECTION 14A SAY-ON-PAY VOTES |          14000 |                0 | FOR         |                                    14000 | FOR                         |  |
| Novocure Limited                    | G6674U108 | 06/04/2025     | A non-binding advisory vote to approve executive compensation.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          28000 |                0 | FOR         |                                    28000 | FOR                         |  |
| Novocure Limited                    | G6674U108 | 06/04/2025     | A non-binding advisory vote to approve executive compensation.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |           3000 |                0 | FOR         |                                     3000 | FOR                         |  |
| Ventyx Biosciences, Inc.            | 92332V107 | 06/04/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). | SECTION 14A SAY-ON-PAY VOTES |          24000 |                0 | FOR         |                                    24000 | FOR                         |  |
| Ventyx Biosciences, Inc.            | 92332V107 | 06/04/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). | SECTION 14A SAY-ON-PAY VOTES |           4800 |                0 | FOR         |                                     4800 | FOR                         |  |
| Xenon Pharmaceuticals Inc           | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          20000 |                0 | FOR         |                                    20000 | FOR                         |  |
| Xenon Pharmaceuticals Inc           | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | FOR         |                                     1000 | FOR                         |  |
| Amicus Therapeutics, Inc.           | 03152W109 | 06/05/2025     | Approval, on an advisory basis, the Company's executive compensation.                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          28000 |                0 | FOR         |                                    28000 | FOR                         |  |
| Moonlake Immunotherapeutics         | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |            800 |                0 | FOR         |                                      800 | FOR                         |  |
| Moonlake Immunotherapeutics         | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |           7200 |                0 | FOR         |                                     7200 | FOR                         |  |
| Tango Therapeutics, Inc.            | 87583X109 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              5 |                0 | FOR         |                                        5 | FOR                         |  |
| Tango Therapeutics, Inc.            | 87583X109 | 06/05/2025     | Non-binding, advisory vote on the frequency of future non-binding, advisory votes on the compensation of our named executive officers.                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              5 |                0 | 1 YEAR      |                                        5 | FOR                         |  |
| Axsome Therapeutics, Inc.           | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |            800 |                0 | FOR         |                                      800 | FOR                         |  |
| Axsome Therapeutics, Inc.           | 05464T104 | 06/06/2025     | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |           5200 |                0 | FOR         |                                     5200 | FOR                         |  |
| Applied Therapeutics, Inc.          | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials.                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          48000 |                0 | FOR         |                                    48000 | FOR                         |  |
| Applied Therapeutics, Inc.          | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the frequency of an advisory vote on the compensation of our named executive officers in future years.                                                                          | SECTION 14A SAY-ON-PAY VOTES |          48000 |                0 | 1 YEAR      |                                    48000 | FOR                         |  |
| Applied Therapeutics, Inc.          | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials.                                                                                    | SECTION 14A SAY-ON-PAY VOTES |             80 |                0 | FOR         |                                       80 | FOR                         |  |
| Applied Therapeutics, Inc.          | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the frequency of an advisory vote on the compensation of our named executive officers in future years.                                                                          | SECTION 14A SAY-ON-PAY VOTES |             80 |                0 | 1 YEAR      |                                       80 | FOR                         |  |
| Applied Therapeutics, Inc.          | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials.                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         432000 |                0 | FOR         |                                   432000 | FOR                         |  |
| Applied Therapeutics, Inc.          | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the frequency of an advisory vote on the compensation of our named executive officers in future years.                                                                          | SECTION 14A SAY-ON-PAY VOTES |         432000 |                0 | 1 YEAR      |                                   432000 | FOR                         |  |
| Corcept Therapeutics Incorporated   | 218352102 | 06/10/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement.                                                                               | SECTION 14A SAY-ON-PAY VOTES |           3500 |                0 | FOR         |                                     3500 | FOR                         |  |
| Corcept Therapeutics Incorporated   | 218352102 | 06/10/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying proxy statement.                                                                               | SECTION 14A SAY-ON-PAY VOTES |          63700 |                0 | FOR         |                                    63700 | FOR                         |  |
| Envista Holdings Corporation        | 29415F104 | 06/10/2025     | To approve on an advisory basis Envista's named executive officer compensation.                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |             55 |                0 | FOR         |                                       55 | FOR                         |  |
| Ironwood Pharmaceuticals, Inc.      | 46333X108 | 06/10/2025     | Approval, by non-binding advisory vote, of the compensation paid to the named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         |                                        1 | FOR                         |  |
| Milestone Pharmaceuticals Inc.      | 59935V107 | 06/10/2025     | Say-on-Pay - Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |              5 |                0 | FOR         |                                        5 | FOR                         |  |
| Milestone Pharmaceuticals Inc.      | 59935V107 | 06/10/2025     | Say-on-Frequency - Non-binding advisory vote on the frequency of the advisory vote on compensation paid to our named executive officers.                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              5 |                0 | 1 YEAR      |                                        5 | FOR                         |  |
| Olema Pharmaceuticals, Inc.         | 68062P106 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |           4000 |                0 | FOR         |                                     4000 | FOR                         |  |
| Olema Pharmaceuticals, Inc.         | 68062P106 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          36000 |                0 | FOR         |                                    36000 | FOR                         |  |
| Alphatec Holdings, Inc.             | 02081G201 | 06/11/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |           5000 |                0 | FOR         |                                     5000 | FOR                         |  |
| Alphatec Holdings, Inc.             | 02081G201 | 06/11/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          28000 |                0 | FOR         |                                    28000 | FOR                         |  |
| Dynavax Technologies Corporation    | 268158201 | 06/11/2025     | To approve, on an advisory basis, executive compensation for certain of our executive officers.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              7 |                0 | FOR         |                                        7 | FOR                         |  |
| Janux Therapeutics, Inc.            | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                        | SECTION 14A SAY-ON-PAY VOTES |              6 |                0 | FOR         |                                        6 | FOR                         |  |
| Janux Therapeutics, Inc.            | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                         | SECTION 14A SAY-ON-PAY VOTES |              6 |                0 | 1 YEAR      |                                        6 | FOR                         |  |
| Puma Biotechnology, Inc.            | 74587V107 | 06/11/2025     | Advisory (non-binding) vote to approve the compensation of Puma Biotechnology, Inc.'s named executive officers as described in the proxy statement.                                                                          | SECTION 14A SAY-ON-PAY VOTES |              2 |                0 | FOR         |                                        2 | FOR                         |  |
| Uniqure N.V.                        | N90064101 | 06/11/2025     | Approval, on an advisory basis, of the compensation of the named executive officers of the Company.                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |           8000 |                0 | FOR         |                                     8000 | FOR                         |  |
| Uniqure N.V.                        | N90064101 | 06/11/2025     | Approval, on an advisory basis, of the compensation of the named executive officers of the Company.                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          80000 |                0 | FOR         |                                    80000 | FOR                         |  |
| Biocryst Pharmaceuticals, Inc.      | 09058V103 | 06/12/2025     | To hold a non-binding, advisory vote regarding executive compensation.                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          40000 |                0 | FOR         |                                    40000 | FOR                         |  |
| Mersana Therapeutics, Inc.          | 59045L106 | 06/12/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |             72 |                0 | FOR         |                                       72 | FOR                         |  |
| Solid Biosciences Inc.              | 83422E204 | 06/12/2025     | The approval of an advisory vote on executive compensation.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          12521 |                0 | FOR         |                                    12521 | FOR                         |  |
| Solid Biosciences Inc.              | 83422E204 | 06/12/2025     | The approval of an advisory vote on executive compensation.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         114696 |                0 | FOR         |                                   114696 | FOR                         |  |
| Spero Therapeutics, Inc.            | 84833T103 | 06/12/2025     | To approve by an advisory vote the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |             12 |                0 | FOR         |                                       12 | FOR                         |  |
| Xencor, Inc.                        | 98401F105 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement.                                                                | SECTION 14A SAY-ON-PAY VOTES |           2000 |                0 | FOR         |                                     2000 | FOR                         |  |
| Xencor, Inc.                        | 98401F105 | 06/12/2025     | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement.                                                                | SECTION 14A SAY-ON-PAY VOTES |          24000 |                0 | FOR         |                                    24000 | FOR                         |  |
| 4D Molecular Therapeutics, Inc.     | 35104E100 | 06/17/2025     | Approval, on an advisory, non-binding basis, of the compensation of the Company's named executive officers ("say-on-pay vote").                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              4 |                0 | FOR         |                                        4 | FOR                         |  |
| 4D Molecular Therapeutics, Inc.     | 35104E100 | 06/17/2025     | Approval, on an advisory, non-binding basis, of the frequency of future advisory say-on-pay votes.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |              4 |                0 | 1 YEAR      |                                        4 | FOR                         |  |
| Apogee Therapeutics, Inc.           | 03770N101 | 06/17/2025     | Vote on the frequency of future advisory votes to approve our named executive officers' compensation.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |            800 |                0 | 1 YEAR      |                                      800 | FOR                         |  |
| Apogee Therapeutics, Inc.           | 03770N101 | 06/17/2025     | Vote on the frequency of future advisory votes to approve our named executive officers' compensation.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |           5435 |                0 | 1 YEAR      |                                     5435 | FOR                         |  |
| Docgo Inc.                          | 256086109 | 06/17/2025     | To approve on a non-binding, advisory basis the compensation of the Company's named executive officers.                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |          64062 |                0 | FOR         |                                    64062 | FOR                         |  |
| Docgo Inc.                          | 256086109 | 06/17/2025     | To approve on a non-binding, advisory basis the compensation of the Company's named executive officers.                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         790000 |                0 | FOR         |                                   790000 | FOR                         |  |
| Liquidia Corporation                | 53635D202 | 06/17/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          10000 |                0 | FOR         |                                    10000 | FOR                         |  |
| Liquidia Corporation                | 53635D202 | 06/17/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |             12 |                0 | FOR         |                                       12 | FOR                         |  |
| Modivcare Inc                       | 60783X104 | 06/17/2025     | A non-binding advisory vote to approve named executive officer compensation.                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |             11 |                0 | FOR         |                                       11 | FOR                         |  |
| Nuvalent, Inc.                      | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |              2 |                0 | FOR         |                                        2 | FOR                         |  |
| Zentalis Pharmaceuticals, Inc.      | 98943L107 | 06/17/2025     | To approve, on an advisory (non-binding) basis, the compensation of our named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |          17000 |                0 | FOR         |                                    17000 | FOR                         |  |
| Addus Homecare Corporation          | 006739106 | 06/18/2025     | To approve, on an advisory non-binding basis, the compensation of the named executive officers.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         |                                        1 | FOR                         |  |
| Addus Homecare Corporation          | 006739106 | 06/18/2025     | To approve, on an advisory non-binding basis, the frequency of holding an advisory, non-binding vote on the compensation of the named executive officers.                                                                    | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | 1 YEAR      |                                        1 | FOR                         |  |
| Axogen, Inc.                        | 05463X106 | 06/18/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.                                                                       | SECTION 14A SAY-ON-PAY VOTES |          18800 |                0 | FOR         |                                    18800 | FOR                         |  |
| Axogen, Inc.                        | 05463X106 | 06/18/2025     | To recommend by a non-binding advisory vote the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers.                                                                | SECTION 14A SAY-ON-PAY VOTES |          18800 |                0 | 1 YEAR      |                                    18800 | FOR                         |  |
| Axogen, Inc.                        | 05463X106 | 06/18/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Company's Proxy Statement.                                                                       | SECTION 14A SAY-ON-PAY VOTES |         139200 |                0 | FOR         |                                   139200 | FOR                         |  |
| Axogen, Inc.                        | 05463X106 | 06/18/2025     | To recommend by a non-binding advisory vote the frequency of future non-binding advisory votes on the compensation of the Company's named executive officers.                                                                | SECTION 14A SAY-ON-PAY VOTES |         139200 |                0 | 1 YEAR      |                                   139200 | FOR                         |  |
| Blueprint Medicines Corporation     | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |            200 |                0 | FOR         |                                      200 | FOR                         |  |
| Blueprint Medicines Corporation     | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |           2268 |                0 | FOR         |                                     2268 | FOR                         |  |
| Guardant Health, Inc.               | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |            600 |                0 | FOR         |                                      600 | FOR                         |  |
| Guardant Health, Inc.               | 40131M109 | 06/18/2025     | Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           5400 |                0 | FOR         |                                     5400 | FOR                         |  |
| Harrow Inc.                         | 415858109 | 06/18/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as presented in the proxy statement.                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          72910 |                0 | FOR         |                                    72910 | FOR                         |  |
| Harrow Inc.                         | 415858109 | 06/18/2025     | To approve, on a non-binding advisory basis, the frequency of a stockholder advisory vote on the compensation of the Company's named executive officers.                                                                     | SECTION 14A SAY-ON-PAY VOTES |          72910 |                0 | 1 YEAR      |                                    72910 | FOR                         |  |
| Mimedx Group, Inc.                  | 602496101 | 06/18/2025     | Advisory approval of executive compensation.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |              6 |                0 | FOR         |                                        6 | FOR                         |  |
| Mimedx Group, Inc.                  | 602496101 | 06/18/2025     | Advisory vote on the frequency of advisory vote on executive compensation.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |              6 |                0 | 1 YEAR      |                                        6 | FOR                         |  |
| Bridgebio Pharma, Inc.              | 10806X102 | 06/20/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |             24 |                0 | FOR         |                                       24 | FOR                         |  |
| Cronos Group, Inc.                  | 22717L101 | 06/20/2025     | Adoption of an advisory (non-binding) resolution to approve the compensation of the Company's named executive officers as disclosed in the proxy statement dated April 25, 2025.                                             | SECTION 14A SAY-ON-PAY VOTES |             15 |                0 | FOR         |                                       15 | FOR                         |  |
| Protagonist Therapeutics, Inc.      | 74365N301 | 06/20/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |              2 |                0 | FOR         |                                        2 | FOR                         |  |
| Protagonist Therapeutics, Inc.      | 74365N301 | 06/20/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          48000 |                0 | FOR         |                                    48000 | FOR                         |  |
| Structure Therapeutics, Inc.        | 86366E106 | 06/23/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | FOR         |                                     1000 | FOR                         |  |
| Structure Therapeutics, Inc.        | 86366E106 | 06/23/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.                                                                      | SECTION 14A SAY-ON-PAY VOTES |           1000 |                0 | 1 YEAR      |                                     1000 | FOR                         |  |
| Structure Therapeutics, Inc.        | 86366E106 | 06/23/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |           8996 |                0 | FOR         |                                     8996 | FOR                         |  |
| Structure Therapeutics, Inc.        | 86366E106 | 06/23/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.                                                                      | SECTION 14A SAY-ON-PAY VOTES |           8996 |                0 | 1 YEAR      |                                     8996 | FOR                         |  |
| United Therapeutics Corporation     | 91307C102 | 06/26/2025     | Advisory resolution to approve executive compensation.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |           7500 |                0 | FOR         |                                     7500 | FOR                         |  |
| Edwards Lifesciences Corporation    | 28176E108 | 05/08/2025     | Advisory vote to approve named executive officer compensation.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |              1 |                0 | FOR         |                                        1 | FOR                         |  |
| Masimo Corporation                  | 574795100 | 09/19/2024     | To provide an advisory vote to approve the compensation of our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          14000 |                0 | FOR         |                                    14000 | FOR                         |  |
| Bluebird Bio, Inc.                  | 09609G209 | 11/06/2024     | The approval, on a non-binding, advisory basis, of the compensation of our named executive officers.                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |         222100 |                0 | FOR         |                                   222100 | FOR                         |  |
| Bluebird Bio, Inc.                  | 09609G209 | 12/04/2025     | The approval, on a non-binding, advisory basis, of the compensation of our named executive officers.                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          40100 |                0 | FOR         |                                    40100 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Birchview Capital, LP

**By (Signature):** Jack Trottier

**By (Printed Signature):** Jack Trottier

**By (Title):** CFO, COO

**Date:** 08/29/2025